Litcius/Paper detail

Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer

Alejandro Ríos-Hoyo, Erin F. Cobain, Laura A. Huppert, Peter D. Beitsch, Thomas A. Buchholz, Laura J. Esserman, Laura van ‘t Veer, Hope S. Rugo, Lajos Pusztai

2024Journal of Clinical Oncology28 citationsDOI

Topics & Concepts

MedicineBreast cancerChemotherapyOncologyEstrogen receptorImmunotherapyInternal medicineHuman Epidermal Growth Factor Receptor 2CancerCancer researchEstrogenEpidermal growth factor receptorBreast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchCancer Cells and Metastasis
Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer | Litcius